@NEJMres360 Journal Club: Hosted by University of Tennessee Health Science Center Internal Medicine Residency Program on Apixaban to Prevent Venous Thromboembolism in Patients with Cancer and Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer

Q&A ends
Post Your Question

Ask a Question

·
Please type something here. This field is required.
·
Upload Image
Remove

Post Your Question

Loading Newsfeed